SlideShare a Scribd company logo
The Freiburg StudyFollow-up Results
– Free Radicals
– Base Inflammation
– Inflammation (hs-CRP)
– Blood Lipids (Cholesterol, Triglycerides)
– Blood Pressure (Systolic, Diastolic)
– Energy Utilization (Heart Rate)
– Sugar Metabolism (Blood Glucose, HbA1c)
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average free radical levels increased 23.7%
Free Radicals
▲
23.7%12 WEEKS
DEPRIVED
2.20
2.00
1.80
1.60
1.40
1.20
1.00
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
uM/min
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their resistance to inflammation had declined 40.5%.
Base Inflammation
▲
40.5%12 WEEKS
DEPRIVED
7.0
6.0
5.0
4.0
3.0
2.0
1.0
0.0
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
uM
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their hs-CRP value had increased 42.8%.
Inflammation: hs-CRP
▲
42.8%12 WEEKS
DEPRIVED
2.40
2.20
2.00
1.80
1.60
1.40
1.20
1.00
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their total cholesterol levels rose 4.6%.
Blood Lipids: Total Cholesterol
▲
4.6%12 WEEKS
DEPRIVED
250
240
230
220
210
200
190
180
170
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average LDL (or bad cholesterol) jumped 10.4%.
Blood Lipids: LDL Cholesterol
▲
10.4%12 WEEKS
DEPRIVED
180
170
160
150
140
130
120
110
100
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average HDL (or good cholesterol) dropped 7.4%.
Blood Lipids: HDL Cholesterol
▼
7.4%12 WEEKS
DEPRIVED
90
85
80
75
70
65
60
55
50
45
40
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average triglyceride levels increased 14.1%.
Blood Lipids: Triglycerides
▲
14.1%12 WEEKS
DEPRIVED
160
140
120
100
80
60
40
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average blood pressure returned to near pre-study levels. In the chart
below, S = systolic blood pressure, D = diastolic blood pressure.
Blood Pressure
SYSTOLIC
DIASTOLIC
▲
3.2%12 WEEKS
DEPRIVED
▲
1.4%12 WEEKS
DEPRIVED
130
120
110
100
90
80
70
60
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
S
D
D D
S
S
mmHg
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average heart rate increased 4.5%.
Energy Utilization: Heart Rate
▲
6 BPM12 WEEKS
DEPRIVED
135.0
130.0
125.0
120.0
115.0
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
bpm
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average blood sugar spikes increased 32.4%.
Blood Glucose Spike
▲
32.4%12 WEEKS
DEPRIVED
60
50
40
30
20
10
0
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mg/dL
FreiburgStudy.com
The Freiburg Study Follow-up Results
12 weeks after participants stopped taking the Peak Performance Pack,
their average HbA1c—which shows an overall picture of average blood
sugar levels over a period of 90 days—increased.
Sugar Metabolism: HbA1c
▲
1.3%12 WEEKS
DEPRIVED
40
39
38
37
36
35
34
33
32
31
30
Before
supplementation
12 weeks with
supplementation
12 weeks
after stopping
mmol/mol

More Related Content

Viewers also liked

Whether to go for underground or aerial deployment
Whether to go for underground or aerial deploymentWhether to go for underground or aerial deployment
Whether to go for underground or aerial deploymentAngelina Li
 
Cabling guide for cisco nexus 9508 switch
Cabling guide for cisco nexus 9508 switchCabling guide for cisco nexus 9508 switch
Cabling guide for cisco nexus 9508 switchAngelina Li
 
Shankar Das Resume
Shankar Das ResumeShankar Das Resume
Shankar Das ResumeShankar Das
 
Chapter 1 profile of tourism and hospitality
Chapter 1  profile of tourism and hospitalityChapter 1  profile of tourism and hospitality
Chapter 1 profile of tourism and hospitalityzaiadlina_1234
 
Chapter 1 intro to hospitality and tourism
Chapter 1 intro to hospitality and tourismChapter 1 intro to hospitality and tourism
Chapter 1 intro to hospitality and tourismAkmal Hafiz
 
PPT for Hotel Management System
PPT for Hotel Management SystemPPT for Hotel Management System
PPT for Hotel Management SystemCharitha Gamage
 
Ice breaker brain teasers
Ice breaker   brain teasersIce breaker   brain teasers
Ice breaker brain teasersAnupriya Balaji
 
10 Creative Thinking Puzzles
10 Creative Thinking Puzzles10 Creative Thinking Puzzles
10 Creative Thinking PuzzlesOH TEIK BIN
 

Viewers also liked (9)

Whether to go for underground or aerial deployment
Whether to go for underground or aerial deploymentWhether to go for underground or aerial deployment
Whether to go for underground or aerial deployment
 
Cabling guide for cisco nexus 9508 switch
Cabling guide for cisco nexus 9508 switchCabling guide for cisco nexus 9508 switch
Cabling guide for cisco nexus 9508 switch
 
Alam CV
Alam CVAlam CV
Alam CV
 
Shankar Das Resume
Shankar Das ResumeShankar Das Resume
Shankar Das Resume
 
Chapter 1 profile of tourism and hospitality
Chapter 1  profile of tourism and hospitalityChapter 1  profile of tourism and hospitality
Chapter 1 profile of tourism and hospitality
 
Chapter 1 intro to hospitality and tourism
Chapter 1 intro to hospitality and tourismChapter 1 intro to hospitality and tourism
Chapter 1 intro to hospitality and tourism
 
PPT for Hotel Management System
PPT for Hotel Management SystemPPT for Hotel Management System
PPT for Hotel Management System
 
Ice breaker brain teasers
Ice breaker   brain teasersIce breaker   brain teasers
Ice breaker brain teasers
 
10 Creative Thinking Puzzles
10 Creative Thinking Puzzles10 Creative Thinking Puzzles
10 Creative Thinking Puzzles
 

Similar to Freiburg_Followup_study

Are all DPP4 inhibitors the same.pptx
Are all DPP4 inhibitors the same.pptxAre all DPP4 inhibitors the same.pptx
Are all DPP4 inhibitors the same.pptxShreeBajrangdasbapaA
 
Clinical Investigation of the LAP-BAND medical device
Clinical Investigation of  the LAP-BAND medical deviceClinical Investigation of  the LAP-BAND medical device
Clinical Investigation of the LAP-BAND medical deviceportlander
 
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...VISHAL CHANDRA
 
Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Ihsaan Peer
 
Freiburg Study Research Findings-2a
Freiburg Study Research Findings-2aFreiburg Study Research Findings-2a
Freiburg Study Research Findings-2aCraig Elliott
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedueda2015
 
PCSK9 Inhibitors PP
PCSK9 Inhibitors PPPCSK9 Inhibitors PP
PCSK9 Inhibitors PPVince Netto
 
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptxLinagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptxAmeetRathod3
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 
Sanitized Company TA Lifestyle Challenge report 2016
Sanitized Company TA  Lifestyle Challenge report 2016Sanitized Company TA  Lifestyle Challenge report 2016
Sanitized Company TA Lifestyle Challenge report 2016Regine du Plessis
 
Intensification Options after basal Insulin Revisited
Intensification Options after basal Insulin RevisitedIntensification Options after basal Insulin Revisited
Intensification Options after basal Insulin RevisitedUsama Ragab
 
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...DoriaFang
 
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemiaEvolocumab in hyperlipidemia
Evolocumab in hyperlipidemianiteshpansari
 
Linagliptin - Speaker training kit India final1234.pptx
Linagliptin - Speaker training kit India final1234.pptxLinagliptin - Speaker training kit India final1234.pptx
Linagliptin - Speaker training kit India final1234.pptxAmeetRathod3
 
Linagliptin in DKD.pptx
Linagliptin in DKD.pptxLinagliptin in DKD.pptx
Linagliptin in DKD.pptxAmeetRathod3
 

Similar to Freiburg_Followup_study (20)

Are all DPP4 inhibitors the same.pptx
Are all DPP4 inhibitors the same.pptxAre all DPP4 inhibitors the same.pptx
Are all DPP4 inhibitors the same.pptx
 
Clinical Investigation of the LAP-BAND medical device
Clinical Investigation of  the LAP-BAND medical deviceClinical Investigation of  the LAP-BAND medical device
Clinical Investigation of the LAP-BAND medical device
 
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...
Diabetese- One reason not to Worry ! A new Clinically researched NATURAL PROD...
 
Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22Beyond metformin dr clayton feb 22
Beyond metformin dr clayton feb 22
 
Freiburg Study Research Findings-2a
Freiburg Study Research Findings-2aFreiburg Study Research Findings-2a
Freiburg Study Research Findings-2a
 
Ueda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayedUeda2015 lilly.the art of insulin dr.mesbah sayed
Ueda2015 lilly.the art of insulin dr.mesbah sayed
 
PCSK9 Inhibitors PP
PCSK9 Inhibitors PPPCSK9 Inhibitors PP
PCSK9 Inhibitors PP
 
TIRZE ASUNCION 18AGO22.pptx
TIRZE ASUNCION 18AGO22.pptxTIRZE ASUNCION 18AGO22.pptx
TIRZE ASUNCION 18AGO22.pptx
 
Linagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptxLinagliptin Endocrinologist Prespective - Case.pptx
Linagliptin Endocrinologist Prespective - Case.pptx
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
Sanitized Company TA Lifestyle Challenge report 2016
Sanitized Company TA  Lifestyle Challenge report 2016Sanitized Company TA  Lifestyle Challenge report 2016
Sanitized Company TA Lifestyle Challenge report 2016
 
DPP4 Inhibitors P4 Seminar2
DPP4 Inhibitors P4 Seminar2DPP4 Inhibitors P4 Seminar2
DPP4 Inhibitors P4 Seminar2
 
Intensification Options after basal Insulin Revisited
Intensification Options after basal Insulin RevisitedIntensification Options after basal Insulin Revisited
Intensification Options after basal Insulin Revisited
 
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
Semaglutide brings breakthroughs in weight management for type 2 diabetes bio...
 
Evolocumab in hyperlipidemia
Evolocumab in hyperlipidemiaEvolocumab in hyperlipidemia
Evolocumab in hyperlipidemia
 
Dapagliflozin
Dapagliflozin Dapagliflozin
Dapagliflozin
 
Incretins based therapy :How Early
Incretins based therapy :How EarlyIncretins based therapy :How Early
Incretins based therapy :How Early
 
Resultados de la inhibición de PCSK9: superando los límites
Resultados de la inhibición de PCSK9: superando los límitesResultados de la inhibición de PCSK9: superando los límites
Resultados de la inhibición de PCSK9: superando los límites
 
Linagliptin - Speaker training kit India final1234.pptx
Linagliptin - Speaker training kit India final1234.pptxLinagliptin - Speaker training kit India final1234.pptx
Linagliptin - Speaker training kit India final1234.pptx
 
Linagliptin in DKD.pptx
Linagliptin in DKD.pptxLinagliptin in DKD.pptx
Linagliptin in DKD.pptx
 

Freiburg_Followup_study

  • 1. The Freiburg StudyFollow-up Results – Free Radicals – Base Inflammation – Inflammation (hs-CRP) – Blood Lipids (Cholesterol, Triglycerides) – Blood Pressure (Systolic, Diastolic) – Energy Utilization (Heart Rate) – Sugar Metabolism (Blood Glucose, HbA1c)
  • 2. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average free radical levels increased 23.7% Free Radicals ▲ 23.7%12 WEEKS DEPRIVED 2.20 2.00 1.80 1.60 1.40 1.20 1.00 Before supplementation 12 weeks with supplementation 12 weeks after stopping uM/min
  • 3. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their resistance to inflammation had declined 40.5%. Base Inflammation ▲ 40.5%12 WEEKS DEPRIVED 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 Before supplementation 12 weeks with supplementation 12 weeks after stopping uM
  • 4. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their hs-CRP value had increased 42.8%. Inflammation: hs-CRP ▲ 42.8%12 WEEKS DEPRIVED 2.40 2.20 2.00 1.80 1.60 1.40 1.20 1.00 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 5. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their total cholesterol levels rose 4.6%. Blood Lipids: Total Cholesterol ▲ 4.6%12 WEEKS DEPRIVED 250 240 230 220 210 200 190 180 170 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 6. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average LDL (or bad cholesterol) jumped 10.4%. Blood Lipids: LDL Cholesterol ▲ 10.4%12 WEEKS DEPRIVED 180 170 160 150 140 130 120 110 100 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 7. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average HDL (or good cholesterol) dropped 7.4%. Blood Lipids: HDL Cholesterol ▼ 7.4%12 WEEKS DEPRIVED 90 85 80 75 70 65 60 55 50 45 40 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 8. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average triglyceride levels increased 14.1%. Blood Lipids: Triglycerides ▲ 14.1%12 WEEKS DEPRIVED 160 140 120 100 80 60 40 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 9. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average blood pressure returned to near pre-study levels. In the chart below, S = systolic blood pressure, D = diastolic blood pressure. Blood Pressure SYSTOLIC DIASTOLIC ▲ 3.2%12 WEEKS DEPRIVED ▲ 1.4%12 WEEKS DEPRIVED 130 120 110 100 90 80 70 60 Before supplementation 12 weeks with supplementation 12 weeks after stopping S D D D S S mmHg
  • 10. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average heart rate increased 4.5%. Energy Utilization: Heart Rate ▲ 6 BPM12 WEEKS DEPRIVED 135.0 130.0 125.0 120.0 115.0 Before supplementation 12 weeks with supplementation 12 weeks after stopping bpm
  • 11. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average blood sugar spikes increased 32.4%. Blood Glucose Spike ▲ 32.4%12 WEEKS DEPRIVED 60 50 40 30 20 10 0 Before supplementation 12 weeks with supplementation 12 weeks after stopping mg/dL
  • 12. FreiburgStudy.com The Freiburg Study Follow-up Results 12 weeks after participants stopped taking the Peak Performance Pack, their average HbA1c—which shows an overall picture of average blood sugar levels over a period of 90 days—increased. Sugar Metabolism: HbA1c ▲ 1.3%12 WEEKS DEPRIVED 40 39 38 37 36 35 34 33 32 31 30 Before supplementation 12 weeks with supplementation 12 weeks after stopping mmol/mol